Cardiovascular disease, including acute myocardial infarction (AMI), is the leading cause of
morbidity and mortality globally, despite well-established treatments. The discovery and …

Over 20% of US Food and Drug Administration (FDA)‐approved drugs in the United States
are metabolized by the hepatic enzyme cytochrome P450 2D6 (CYP2D6). The gene …

Embracing Genetic Diversity to Improve Black Health Ideally, race will be replaced with genetic
ancestry as a variable in medical research and practice. But until more ancestry data are …

We explored ancestry-related differences in the genetic architecture of whole-blood gene
expression using whole-genome and RNA sequencing data from 2,733 African Americans, …

Cytochrome P450 (CYP)-derived epoxyeicosatrienoic acids (EETs) exhibit potent cardiovascular
protective effects in preclinical models, and promoting the effects of EETs has emerged …

The association between the c.521T>C variant allele in SLCO1B1 (reference single nucleotide
polymorphism (rs)4149056) and simvastatin‐induced myotoxicity was discovered over a …

Pharmacogenetics can improve clinical outcomes by reducing adverse drug effects and
enhancing therapeutic efficacy for commonly used drugs that treat a wide range of …

Background: Low-density lipoprotein cholesterol (LDL-C) response to statin therapy has not
been fully elucidated in real-world populations. The primary objective of this study was to …

We recently demonstrated that selective expression of the Rho GTPase-activating protein
ARHGAP42 in smooth muscle cells (SMCs) controls blood pressure by inhibiting RhoA-…

Importance Prior studies suggested that metformin may be associated with reduced dementia
incidence, but associations may be confounded by disease severity and prescribing trends…